Humana Inc. Reports $39.6 Billion Revenue in Q1 2026, Net Income Declines

Humana Inc. reported significant financial results for the first quarter of 2026, with total revenues reaching $39.6 billion, a 23.5% increase from $32.1 billion in the same period of 2025. The growth was primarily driven by a 23.6% rise in premiums, which amounted to $37.7 billion, largely attributed to increased membership in Medicare Advantage plans and higher per-member premiums due to enhanced funding from the Centers for Medicare and Medicaid Services (CMS). However, net income attributable to Humana decreased to $1.19 billion, or $9.83 per diluted share, compared to $1.24 billion, or $10.30 per diluted share, in the prior year, reflecting challenges such as valuation adjustments related to non-consolidating minority interests and costs associated with ongoing transformation initiatives.

The company’s operating expenses also saw a notable increase, rising 25.9% to $37.9 billion, driven by a 27% increase in benefits expenses, which totaled $33.7 billion. This increase in benefits expense was influenced by the growth in Medicare membership and the associated higher benefit ratios, which rose to 89.4% from 87.0% in the previous year. Operating costs increased by 19.1% to $4.0 billion, but the operating cost ratio improved slightly to 10.2% from 10.6%, indicating enhanced administrative efficiency despite rising costs.

In terms of strategic developments, Humana completed the acquisition of MaxHealth, a primary care organization, for approximately $908 million in cash. This acquisition is expected to enhance Humana's integrated care delivery model, which aims to improve health outcomes and affordability for its members. The company is also implementing value creation initiatives aimed at optimizing its cost structure and operational efficiency, which resulted in charges of $98 million in the first quarter of 2026, compared to $24 million in the same period of 2025.

Operationally, Humana reported a total membership of approximately 17.7 million as of March 31, 2026, a 19.4% increase from the previous year. This includes significant growth in individual Medicare Advantage members, which rose by 22.6% to 6.4 million. The company also noted that 64% of its individual Medicare Advantage members were in value-based care relationships, reflecting its commitment to integrated care. The company’s cash and cash equivalents increased to $5.0 billion, up from $4.2 billion at the end of 2025, supported by strong operating cash flows of $1.3 billion during the quarter.

Looking ahead, Humana remains focused on leveraging its integrated care delivery model to drive growth and improve member experiences. The company anticipates continued membership growth and is committed to enhancing its operational efficiencies through ongoing transformation initiatives. However, it also acknowledges potential challenges from regulatory changes and market conditions that could impact its financial performance in the future.